70 related articles for article (PubMed ID: 34543391)
1. Current strategies for the design of PROTAC linkers: a critical review.
Troup RI; Fallan C; Baud MGJ
Explor Target Antitumor Ther; 2020; 1(5):273-312. PubMed ID: 36046485
[TBL] [Abstract][Full Text] [Related]
2. The impact of tumour pH on cancer progression: strategies for clinical intervention.
Ward C; Meehan J; Gray ME; Murray AF; Argyle DJ; Kunkler IH; Langdon SP
Explor Target Antitumor Ther; 2020; 1(2):71-100. PubMed ID: 36046070
[TBL] [Abstract][Full Text] [Related]
3. Current options and future directions of systemic therapy for advanced biliary tract cancer.
Prete MG; Cammarota A; D'Alessio A; Zanuso V; Rimassa L
Explor Target Antitumor Ther; 2021; 2(5):416-433. PubMed ID: 36045701
[TBL] [Abstract][Full Text] [Related]
4. Striking a balance: PIP
Tariq K; Luikart BW
Explor Neuroprotective Ther; 2021; 1():86-100. PubMed ID: 35098253
[TBL] [Abstract][Full Text] [Related]
5. Dissemination feature based on PET/CT is a risk factor for diffuse large B cell lymphoma patients outcome.
Wang F; Cui S; Lu L; Shao X; Yan F; Liu Y; He B; Wang J; Cao Y; Yue Y; Wang Y; Gu W
BMC Cancer; 2023 Nov; 23(1):1165. PubMed ID: 38030989
[TBL] [Abstract][Full Text] [Related]
6. LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma.
Lossos C; Bayraktar S; Weinzierl E; Younes SF; Hosein PJ; Tibshirani RJ; Sutton Posthumus J; DeAngelis LM; Raizer J; Schiff D; Abrey L; Natkunam Y; Lossos IS
Br J Haematol; 2014 Jun; 165(5):640-8. PubMed ID: 24571259
[TBL] [Abstract][Full Text] [Related]
7. Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models.
Mossadegh-Keller N; Brisou G; Beyou A; Nadel B; Roulland S
Front Immunol; 2021; 12():683597. PubMed ID: 34335584
[TBL] [Abstract][Full Text] [Related]
8. HGAL inhibits lymphoma dissemination by interacting with multiple cytoskeletal proteins.
Jiang X; Lu X; Gentles AJ; Zhao D; Wander SA; Zhang Y; Natkunam Y; Slingerland J; Reis IM; Rabinovich B; Abdulreda MH; Moy VT; Lossos IS
Blood Adv; 2021 Dec; 5(23):5072-5085. PubMed ID: 34543391
[TBL] [Abstract][Full Text] [Related]
9. miR-155 regulates HGAL expression and increases lymphoma cell motility.
Dagan LN; Jiang X; Bhatt S; Cubedo E; Rajewsky K; Lossos IS
Blood; 2012 Jan; 119(2):513-20. PubMed ID: 22096245
[TBL] [Abstract][Full Text] [Related]
10. HGAL, a germinal center specific protein, decreases lymphoma cell motility by modulation of the RhoA signaling pathway.
Jiang X; Lu X; McNamara G; Liu X; Cubedo E; Sarosiek KA; Sánchez-García I; Helfman DM; Lossos IS
Blood; 2010 Dec; 116(24):5217-27. PubMed ID: 20844236
[TBL] [Abstract][Full Text] [Related]
11. Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation.
Natkunam Y; Lossos IS; Taidi B; Zhao S; Lu X; Ding F; Hammer AS; Marafioti T; Byrne GE; Levy S; Warnke RA; Levy R
Blood; 2005 May; 105(10):3979-86. PubMed ID: 15677569
[TBL] [Abstract][Full Text] [Related]
12. Germinal center-specific protein human germinal center associated lymphoma directly interacts with both myosin and actin and increases the binding of myosin to actin.
Lu X; Kazmierczak K; Jiang X; Jones M; Watt J; Helfman DM; Moore JR; Szczesna-Cordary D; Lossos IS
FEBS J; 2011 Jun; 278(11):1922-31. PubMed ID: 21447067
[TBL] [Abstract][Full Text] [Related]
13. Conditional expression of HGAL leads to the development of diffuse large B-cell lymphoma in mice.
Raboso-Gallego J; Casado-García A; Jiang X; Isidro-Hernández M; Gentles AJ; Zhao S; Natkunam Y; Blanco O; Domínguez V; Pintado B; Alonso-López D; De Las Rivas J; Vicente-Dueñas C; Lossos IS; Sanchez-Garcia I
Blood; 2021 Apr; 137(13):1741-1753. PubMed ID: 33024996
[TBL] [Abstract][Full Text] [Related]
14. Interplay between HGAL and Grb2 proteins regulates B-cell receptor signaling.
Jiang X; Lu X; Zhang Y; Lacaria L; Schuchardt BJ; Mikles DC; Magistri M; García-Ramírez I; Sanchez-Garcia I; Farooq A; Verdun RE; Abdulreda MH; Moy VT; Lossos IS
Blood Adv; 2019 Aug; 3(15):2286-2297. PubMed ID: 31362927
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
